EyePoint Inc (EYPT)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$2.98

Buy

$2.99

arrow-down$-0.08 (-2.61%)

Prices updated at 14 Oct 2026, 18:11 EDT

Prices minimum 15 mins delay

Prices in USD

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's ...

NASDAQ

-1.61%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

Key dates

	Forecast date
Half yearly results	Aug 2027
Annual general meeting	Jun 2027
Annual report	Mar 2027
Final results	Mar 2027

	Previous date
Half yearly results	Aug 2026
Annual general meeting	Jun 2026
Annual report	Mar 2026
Final results	Mar 2026

Company reports

31 Dec 2025

Annual Report

30 Jun 2026

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.